Literature DB >> 8034732

Erythropoietin induces tyrosine phosphorylation and activation of phospholipase C-gamma 1 in a human erythropoietin-dependent cell line.

H Y Ren1, N Komatsu, R Shimizu, K Okada, Y Miura.   

Abstract

Erythropoietin (Epo) is the major regulator of the proliferation and differentiation of erythroid precursors through interaction with its receptor (Epo-R). Although Epo-R lacks a tyrosine kinase consensus sequence within its intracellular domain, the addition of its ligand to Epo-responsive cells, UT-7/Epo, induces the rapid and transient tyrosine phosphorylation of 145-, 130-, 80-, and 40-kDa cellular proteins. Tyrosine phosphorylation of these proteins occurred dose- and time-dependently. We showed that the tyrosine phosphorylated 145- kDa protein is identical to phospholipase C-gamma 1 (PLC-gamma 1). Tyrosine phosphorylation of this protein is detectable within 30 s and almost reaches the maximum at 1 min. This can last up to 10 min and declines thereafter. Additionally, in Epo-stimulated cells, PLC-gamma 1 become physically associated with 80- and 40-kDa proteins which have been tyrosine-phosphorylated in response to Epo. The activity of PLC-gamma 1 was also investigated using inositol 1,4,5-trisphosphate (Ins-P3) as an indicator. We found that stimulation of UT-7/Epo cells with Epo induces a significant accumulation of Ins-P3. This effect is dose-dependent and occurs very rapidly. The production of Ins-P3 can explain the Epo-induced mobilization of calcium from intracellular stores in these cells. These results demonstrate that Epo induces tyrosine phosphorylation and activation of PLC-gamma 1 to produce Ins-P3 and then it mobilizes calcium from intracellular stores. This signal transduction pathway may play a role in regulating the proliferation of erythroid cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034732

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Targeted deletion of Minpp1 provides new insight into the activity of multiple inositol polyphosphate phosphatase in vivo.

Authors:  H Chi; X Yang; P D Kingsley; R J O'Keefe; J E Puzas; R N Rosier; S B Shears; P R Reynolds
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response.

Authors:  F W Quelle; D Wang; T Nosaka; W E Thierfelder; D Stravopodis; Y Weinstein; J N Ihle
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  Downregulation of erythropoietin receptor by overexpression of phospholipase C-gamma 1 is critical for decrease on focal adhesion in transformed cells.

Authors:  Jin Ku Kang; Chang-Hyun Chang; Hyo Jung Nam; Sung-Kuk Kim; Keun Jae Ahn; Heon Seok; Sang Joon Park; Yoon Joong Kang; Young Suk Jo; Minho Shong; Ho Kim
Journal:  Cell Oncol (Dordr)       Date:  2011-01-18       Impact factor: 6.730

4.  Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal- and luminal-like breast cancer xenografts.

Authors:  Evita M Lindholm; Alexandr Kristian; Hawa Nalwoga; Kristi Krüger; Ståle Nygård; Lars A Akslen; Gunhild M Mælandsmo; Olav Engebraaten
Journal:  Mol Oncol       Date:  2012-03-31       Impact factor: 6.603

5.  TRPC3 is the erythropoietin-regulated calcium channel in human erythroid cells.

Authors:  Qin Tong; Iwona Hirschler-Laszkiewicz; Wenyi Zhang; Kathleen Conrad; David W Neagley; Dwayne L Barber; Joseph Y Cheung; Barbara A Miller
Journal:  J Biol Chem       Date:  2008-02-14       Impact factor: 5.157

6.  Bovine growth hormone induces oscillations in cytosolic free Ca2+ in single rat hepatocytes.

Authors:  I Marrero; A K Green; P H Cobbold; C J Dixon
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

7.  Activation of phospholipase C gamma in Schizosaccharomyces pombe by coexpression of receptor or nonreceptor tyrosine kinases.

Authors:  S Arkinstall; M Payton; K Maundrell
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.